Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication

British Journal of Surgery

Volumn 99, Issue 1, 2012, Pages 16-28

  Frans, F A ^a   Bipat, S ^a   Reekers, J A ^a   Legemate, D A ^a   Koelemay, M J W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DISEASE; EXERCISE; EXERCISE TEST; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; INTERMITTENT CLAUDICATION; OUTCOME ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY PREVENTION;

ANGIOPLASTY, BALLOON; AORTIC DISEASES; EXERCISE; EXERCISE TEST; FEMORAL ARTERY; HUMANS; ILIAC ARTERY; INTERMITTENT CLAUDICATION; OUTCOME ASSESSMENT (HEALTH CARE); POPLITEAL ARTERY; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION;

EID: 82955249237     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7656     Document Type: Review

References (46)

1. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, et al., Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599-1606. (Pubitemid 33010284)
2. Meru AV, Mittra S, Thyagarajan B, Chugh A,. Intermittent claudication: an overview. Atherosclerosis 2006; 187: 221-237. (Pubitemid 43983033)
3. Breek JC, Hamming JF, De Vries J, Aquarius AE, van Berge Henegouwen DP,. Quality of life in patients with intermittent claudication using the World Health Organisation (WHO) questionnaire. Eur J Vasc Endovasc Surg 2001; 21: 118-122. (Pubitemid 32243903)
4. Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS,. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 2009; 38: 463-474.
5. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, et al., Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009; 301: 165-174.
6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG,; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67. (Pubitemid 46151680)
7. Bosch JL, Hunink MG,. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204: 87-96. (Pubitemid 27281713)
8. Gardner AW, Poehlman ET,. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995; 274: 975-980.
9. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH,. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev 2006; (2)CD005263.
10. Wind J, Koelemay MJ,. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials. Eur J Vasc Endovasc Surg 2007; 34: 1-9. (Pubitemid 46863197)
11. Tetteroo E, van der Graaf Y, Bosch JL, Bosch JL, van Engelen AD, Hunink MG, et al., Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998; 351: 1153-1159. (Pubitemid 28171817)
12. Fowkes FG, Gillespie IN,. Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev 2000; (2)CD000017.
13. Creasy TS, McMillan PJ, Fletcher EW, Collin J, Morris PJ,. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg 1990; 4: 135-140. (Pubitemid 20172197)
14. Perkins JM, Collin J, Creasy TS, Fletcher EW, Morris PJ,. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg 1996; 11: 409-413. (Pubitemid 26192844)
15. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al., Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg 1997; 26: 551-557. (Pubitemid 27459599)
16. Whyman MR, Fowkes FG, Kerracher EM, Gillespie IN, Lee AJ, Housley E, et al., Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996; 12: 167-172. (Pubitemid 26293573)
17. Wilson SE,. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients. Ann Vasc Surg 2010; 24: 498-502.
18. Hobbs SD, Marshall T, Fegan C, Adam DJ, Bradbury AW,. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty. J Vasc Surg 2006; 43: 40-46. (Pubitemid 43083506)
19. Nylaende M, Kroese AJ, Morken B, Stranden E, Sandbaek G, Lindahl AK, et al., Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study. Vasc Med 2007; 12: 275-283.
20. Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, et al., The Oslo balloon angioplasty versus conservative treatment study (OBACT)-the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2007; 33: 3-12. (Pubitemid 44856515)
21. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA, et al.,; Mimic Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. Eur J Vasc Endovasc Surg 2008; 36: 680-688.
22. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG,. Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training-randomized controlled trial. Radiology 2009; 250: 586-595.
23. Spronk S, Bosch JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG,. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial. J Vasc Surg 2008; 48: 1472-1480.
24. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, et al., Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Ann Vasc Surg 2010; 24: 69-79.
25. Kruidenier LM, Nicolaï SP, Rouwet EV, Peters RJ, Prins MH, Teijink JA,. Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomised clinical trial. J Vasc Interv Radiol 2011; 227: 961-968.
26. Moher D, Liberati A, Tetzlaff J, Altman DG,; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
27. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF,. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
28. Verhagen A, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al., The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235-1241. (Pubitemid 29009523)
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-560.
30. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al.,; AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-2372. (Pubitemid 43947981)
31. Flu HC, Tamsma JT, Lindeman JH, Hamming JF, Lardenoye JH,. A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD. Eur J Vasc Endovasc Surg 2010; 39: 70-86.
32. Mohler ER III, Hiatt WR, Creager MA,. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 2003; 108: 1481-1486. (Pubitemid 37176455)
33. Mondillo S, Ballo P, Barbati R, Guerrini F, Ammaturo T, Agricola E, et al., Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 2003; 114: 359-364. (Pubitemid 36513683)
34. Landry GJ,. Functional outcome of critical limb ischemia. J Vasc Surg 2007; 45 (Suppl A): A141-A148.
35. De Vries M, Ouwendijk R, Kessels AG, de Haan MW, Flobbe K, Hunink MG, et al., Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 2005; 41: 261-268. (Pubitemid 40342477)
36. Mehta T, Venkata Subramaniam A, Chetter I, McCollum P,. Disease-specific quality of life assessment in intermittent claudication: review. Eur J Vasc Endovasc Surg 2003; 25: 202-208. (Pubitemid 36527612)
37. Regensteiner JG, Steiner JF, Hiatt WR,. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996; 23: 104-115. (Pubitemid 26037967)
38. Hiatt WR, Hirsch AT, Regensteiner JG, Brass EP,. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation 1995; 92: 614-621.
39. Greig C, Butler F, Skelton D, Mahmud S, Young A,. Treadmill walking in old age may not reproduce the real life situation. J Am Geriatr Soc 1993; 41: 15-18. (Pubitemid 23018044)
40. Nicolaï SP, Viechtbauer W, Kruidenier LM, Candel MJ, Prins MH, Teijink JA,. Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg 2009; 50: 322-329.
41. McDermott MM, Ades PA, Dyer A, Guralnik JM, Kibbe M, Criqui MH,. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg 2008; 48: 1231-1237.
42. Hopewell S, McDonald S, Clarke M, Egger M,. Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev 2007; (2)MR000010.
43. Shalhoub J, Hamish M, Davies AH,. Supervised exercise for intermittent claudication-an under-utilised tool. Ann R Coll Surg Engl 2009; 91: 473-476.
44. Zeller T, Schmitmeier S, Tepe G, Rastan A,. Drug-coated balloons in the lower limb. Cardiovasc Surg 2011; 52: 235-243.
45. Joost A, Kurowski V, Radke PW,. Drug eluting balloons for the treatment of coronary artery disease: What can we expect? World J Cardiol 2010; 2: 257-261.
46. Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, et al.,;. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg 2008; 47: 1356-1363.